Department of Ophthalmology, HELIOS Klinikum Erfurt, Erfurt, Germany.
J Cataract Refract Surg. 2013 May;39(5):759-69. doi: 10.1016/j.jcrs.2012.11.033.
To evaluate the visual outcome of refractive lenticule extraction in eyes with myopic astigmatism using the Visumax femtosecond laser.
Department of Ophthalmology, HELIOS Klinikum Erfurt, Erfurt, Germany.
Nonrandomized clinical trials.
The data set encompassed treatments of sphere and astigmatism. Vector analysis was performed to study the astigmatic results at each follow-up visit at 1 week and 1, 3, and 6 months. Visual outcomes were analyzed for the 6-month follow-up period.
The data evaluated was a complete set of refractive data of 182 treatments (87 left eyes, 95 right eyes). Efficacy, predictability, and safety with regard to astigmatic correction were comparable to the results with U.S. Food and Drug Administration-approved excimer lasers. At 6 months, the mean error ratio was 0.68 ± 0.75 (SD) and the mean correction ratio was 1.11 ± 0.69. There was slight astigmatic undercorrection (approximately 10%) over time. The residuum of the linear regression analysis of the predictability plot was approximately 0.4 diopter. Ninety-six percent of the eyes had a corrected distance visual acuity (CDVA) of 20/20 or better; no eye had a CDVA worse than 20/32.
Femtosecond refractive lenticule extraction is an effective procedure for correcting myopic astigmatism.
评估使用 Visumax 飞秒激光进行矫正近视散光的屈光性晶状体切除术的视力结果。
德国爱尔福特 HELIOS 医院眼科。
非随机临床试验。
数据集包括球镜和散光的治疗。进行向量分析,以研究在 1 周、1、3 和 6 个月每次随访时的散光结果。对 6 个月的随访期进行视力结果分析。
评估的数据是 182 次治疗(87 只左眼,95 只右眼)的完整屈光数据。在散光矫正方面,疗效、可预测性和安全性与美国食品和药物管理局批准的准分子激光相当。6 个月时,平均误差比为 0.68 ± 0.75(SD),平均矫正比为 1.11 ± 0.69。随着时间的推移,出现轻微的散光欠矫(约 10%)。预测图线性回归分析的残差约为 0.4 屈光度。96%的眼矫正视力(CDVA)达到 20/20 或更好;没有眼的 CDVA 差于 20/32。
飞秒屈光性晶状体切除术是矫正近视散光的有效方法。